Effects of Suxiao Jiuxin Pill () on Oxidative Stress and Inflammatory Response in Rats with Experimental Atherosclerosis  by LI, Chun-shen et al.
Journal of Traditional Chinese Medicine, June 2011; 31(2): 107-111 107
Basic Investigations 
Effects of Suxiao Jiuxin Pill (䗳ᬜᬥᖗЌ) on Oxidative Stress and 
Inflammatory Response in Rats with Experimental Atherosclerosis 
LI Chun-shen ᴢ᯹⏅ 1, QU Zhu-qiu᳆ネ⾟ 1, WANG Sha-sha⥟㥢㥢 1, HAO Xu-wen䚱ᯁ䳃 1, 
ZHANG Xiu-qinᓴ⾔⨈ 1, GUAN Jing݇᱊ 1, and HAN Fei䶽䳣 3  
Objective: To observe the preventive role of Suxiao Jiuxin Pill (SX䗳ᬜᬥᖗЌ) on atherosclerosis (AS) and to 
probe into the mechanism in the atherosclerosis rat model.
Methods: The AS rat model was established by a high fat diet and a large dose of calcium (vitamin D3, 0.6 million 
U/kg, i.p, once). Sixty healthy male adult Sprague-Dawlay (SD) rats were randomly divided into 6 groups, a normal 
control group (N), a model group (M), a SX low dose group (SXL), a SX middle dose group (SXM), a SX high 
dose group (SXH), and an atorvastatin group (ATO) (n=10 in each group). The rats in the treatment groups were 
given with the specific drugs from the first day by oral administration, and the normal control group and the model 
group were given with normal saline for 12 weeks. Afterwards, the content of malondialdehyde (MDA), the activity 
of superoxide dismutase (SOD) and the content of oxidized low density lipoprotein (ox-LDL) in the serum were 
detected. In addition, the expression of peroxisome proliferator-activated receptor Ȗ (PPARȖ) and nuclear factor 
kappa-light-chain-enhancer of activated B cells (NF-țB) proteins were tested by Western-blot method.  
Results: The serum ox-LDL and MDA level significantly decreased, SOD activity increased in the SX middle, high 
dose groups and the atorvastatin group compared to the model group (all P<0.05). While the expression of PPARȖ
and NF-țb proteins significantly decreased in the SX low, middle, high dose groups and the atorvastatin group 
compared to the model group (all P<0.01), with the best effect in the SX high dose group .These results indicate 
that SX could elevate the activity of serum SOD, decrease serum level of MDA and ox-LDL, and reduce the 
expression of PPARȖ and NF-țB proteins.  
Conclusion: SX plays an important role in anti-inflammation and inhibition of oxidative stress, which possibly are 
the mechanism of its preventing and treating atherosclerosis.  
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The pathogenesis of atherosclerosis (AS) is very complex. 
A recent study briefly summarized the risk factors of 
atherosclerosis, namely, hyperlipidemia, hypertension, 
smoking, diabetes, hyperinsulinemia, genetic factors, 
gender and age.1 Oxidative stress and inflammation may 
be involved in the formation and development of 
atherosclerosis. When oxidative stress happens, vascular 
wall cells produce excessive reactive oxygen species 
(ROS) which can cause peroxidation of lipid and 
irreversible damage of cell membrane, proteins and DNA. 
Furthermore, these damages further lead to the oxidative 
injury of the vascular wall, manifesting as the impairment 
of the endothelial cell function and structure, migration 
of monocytes / macrophages, hyperplasia of smooth 
muscle cells and fibroblasts, and degradation of 
extracellular matrix. Ultimately, AS develops.2
Inflammation may promote the formation, development 
and rupture of atherosclerotic plaque. Previous studies 
have shown that monocytes / macrophages accumulate in 
atherosclerotic plaque and produce pro-inflammatory 
cytokines.3 Suxiao Jiuxin Pill (SX 䗳ᬜᬥᖗЌ ) is 
composed of Chuanxiong (Rhizoma Chuanxiong) and 
Bingpian (Borneolum) for the treatment of coronary heart 
disease and angina pectoris. With the character of small 
doses and rapid effect, SX is widely used as the clinical 
emergency medicine with no obvious discomfort,1no side 
effects and no drug resistance.4 Some studies suggest that 
SX can promote angiogenesis in the myocardial ischemia 
area, protecting ischemic myocardium and reducing the 
size of myocardial infarct.5 SX can block calcium 
channel,6 relax vascular smooth muscle, significantly 
reduce the blood viscosity, lower the erythrocyte 
aggregation index and area, and substantially increase the 
red blood cell deformability.7 Intensive study also finds 
that the drug can prevent the formation of AS. In the 
authors’ experiment, they treated experimental 
atherosclerosis rats by different doses of SX and 
observed the impact of SX on atherosclerosis and 
explored its possible mechanisms.
MATERIALS AND METHODS
Animals  
Sanitary degree healthy Sprague-Dawlay (SD) rats, male, 
aged 2–3 months old, weighing ˄256±20˅ g, a total of 
60, were purchased from the Laboratory Animal Center 
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of Radiation Medicine Institute, Chinese Academy of 
Medical Sciences. The Medical animal license No: 
SCXK (Tianjin) 2005-0001.  
Experimental Drugs  
Vitamin D3 injection was produced by Shanghai General 
Pharmaceutical Co., 1 mL × 10 pieces/box, batch number: 
061001, and used for increasing calcium load so as to 
establish the atherosclerosis rat model.  
SX (40 mg/tablet), a present from the Sixth Chinese 
Drugs Factor of Tianjin Zhongxin Pharmaceutical Co., 
was principally composed by Chuan Xiong (Rhizoma 
Chuanxiong) and Bing Pian (Borneolum).   
Atorvastatin, a selective inhibitor of HMG-CoA red-
uctase with the function of reducing plasma cholesterol 
and lipoprotein levels, was produced by Pfizer 
Pharmaceuticals, Inc, USA, 20 mg × 7 pieces/box, batch 
number: 75837003, and used as a control drug.  
Modeling and Grouping  
After being fed with ordinary particles food for one week, 
the animals were randomly divided into 6 groups, normal 
control group (N), model group (M), SX low dose group 
(SXL), SX middle dose group (SXM), Suxiao Jiuxin Pill 
high dose group (SXH), Atorvastatin group (ATO),10 rats 
in each group.  
The AS rat model was prepared according to the 
literature.8 The rats in the model group and the treatment 
groups were injected intraperitonealy with vitamin D3, 
0.6 million U/kg, once , and began to feed high fat diet. 
The rats in the control group were injected with the same 
volume of saline and fed with basal diet. The experiment 
lasted 12 weeks.  
Dosages and Methods of Administration  
The dosages of adult (SX 15 pills/day, 40 mg/pill; 
atorvastatin 40 mg/day) were converted into the dosage 
of the rat according to the weight coefficients: Suxiao 
Jiuxin Pill low, medium and high dose were 60 mg • kg-1
• d-1, 600 mg • kg-1 • d-1, 1800 mg • kg-1 • d-1  
respectively, while atorvastatin dosage was 4 mg • kg-1 • 
d-1. The drugs were grinded into a powder and dissolved 
in distilled water, and then given by gavage in 0.5
mL/100 g. The drugs were administrated in the treatment 
groups from the first day of the modeling, while in the 
model group and the normal control group 0.5 mL/100 g 
of saline was given, once a day, lasting for 12 weeks. The 
rats were weighted once a week to adjust the dosages of 
drugs.  
Specimen Collection  
After the last administration, all of the rats were fasted 
for 12 hours, and then weighed and killed in the next 
morning. The blood was taken from the femoral artery 
and centrifuged at 3000 r/min for 15 min. Then the serum 
was separated and kept in a refrigerator at -20 ć. The 
aortic arch was separated and put into a vial and stored in 
liquid nitrogen immediately for Western blot detection. 
As some animals died during the experiment, 8 samples 
were collected randomly in each group.   
Detection of Serum Indicators  
Serum content of malondialdehyde (MDA) and serum 
activity of superoxide dismutase (SOD) were detected by 
biochemical methods. The content of oxidized low 
density lipoprotein (ox-LDL) was detected with 
enzyme-linked immunosorbent assay (ELISA), and the 
kits used in the experiment were provided by the ADL 
biotechnology company in USA.  
Detection of Expression of NF-țB and PPARȖ
Proteins by Western-blot Method
The aortic arch samples were taken from the liquid 
nitrogen to extract proteins, which were separated by 
denatured polyacrylamide gel and then the 12% sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS 
-PAGE). Finally, the average luminosity of the gel 
electrophoresis image was analyzed.  
Data Analysis  
SPSS 11.0 software was used for statistical analysis. 
Measurement data were expressed as mean ± standard 
deviation ( xfs), and the comparison between groups 
was done by single factor analysis of variance (one-way 
ANOVA). For pair comparison between groups, LSD 
method was used when the variance was homogeneous, 
while DUNNET'S T3 method was used when the 
variance was arrhythmic. P <0.05 was considered 
statistically significant.   
RESULTS 
Effect of SX on ox-LDL Level in AS Rats 
As shown in Table 1 and Figure1, the serum ox-LDL 
level in the model group was about 5 times higher (P
<0.05) than that in the normal control group. Compared 
to the model group, the serum ox-LDL level in the SX 
middle, high dose groups and the atorvastatin group 
significantly decreased (P<0.05), and there was a 
significant difference in the serum ox-LDL level between 
the SX middle and high dose groups (P<0.05).  
Table 1. Serum ox-LDL levels in each group of the rats  
(ȝg/dL, xfs, n=8 in each group) 
Group ox-LDL 
N 17.26±3.92 
M  85.42±6.04Ƹ
SXL  85.21±5.52Ÿ
SXM  70.54±4.05ƿ
SXH  53.95±4.64ƿ
ATO  51.97±3.36ƿ
Notes: ƸCompared to the N group, P<0.05; ŸCompared to M 
group; ƿCompared to M group, P<0.05.
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Figure 1. Serum ox-LDL levels in each group of the rats 
Effects of SX on Serum MDA Content and SOD 
Activity in AS Rats 
As seen in Table 2, Figure 2 and Figure 3, the serum 
MDA content significantly increased and SOD activity 
decreased in the model group compared to the normal 
control group (both P<0.05). Compared to the model 
group, serum MDA level decreased and SOD activity 
increased in the SX middle, high dose groups and the 
atorvastatin group (all P<0.05).  
Table 2. Serum MDA contents and SOD activities in 
each group of the rats ( xfs, n=8 in each group) 
Group MDA(nmol/L) SOD(U/mL)
N 5.17±0.43 165.36±13.80
M  6.44±0.35Ƹ  143.05±12.91Ƹ
SXL 6.30±0.50 152.41±8.05
SXM  5.73±0.25ƿ 163.46±6.54ƿ
SXH  5.23±0.32ƿ 169.14±4.35ƿ
ATO  5.28±0.44ƿ 166.15±7.80ƿ
Notes: ƸCompared to the N group, P<0.05; ƿCompared to M 
group, P<0.05.
Figure 2. Serum MDA levels in each group of the rat  
       Figure 3. Serum SOD activities in each group of the rats 
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Expression of PPARȖ and NF-kB in the Aortic Arch 
in the Groups
As shown in Table 3, Figure 4, compared to the normal 
control group, the expression of PPARȖ and NF-țb 
proteins significantly increased in the model group (both 
P<0.01); while compared to the model group, the 
expression of PPARȖ and NF-țb proteins significantly 
decreased in the SX low, middle, high dose groups and 
the atorvastatin group (all P<0.01), with the best effect in 
the SX high dose group .  
Table 3. Expression of PPARȖ and NF-kB in the aorta 
arch in each group of the rats ( xfs, n=8 in each group) 
Group PPARȖ NF-kB 
N  7.59±0.89 12.20±0.35 
M   33.76±1.10Ÿ  22.15±1.07Ÿ
SXL  18.70±0.56ƾ 19.15±0.47ƾ
SXM  11.11±0.94ƾ 15.65±0.72ƾ
SXH 9.36±0.92ƾƸ 15.20±0.89ƾ
ATO  19.48±0.82ƾ 15.39±0.60ƾ
Notes: Compared to N group, ŸP<0.01; Compared with M group, 
ƾP<0.05.
Figure 4. Expression of PPARȖ and NF-kB in the aorta arch in each group of the rats  
DISCUSSION
Atherosclerosis (AS) is a chronic inflammatory lesion in 
large and middle artery intima.9 One of the major risk 
factors causing the chronic inflammatory disease is 
oxidative modification of lipoproteins, especially, injury 
of endothelial cells induced by oxidized low density 
lipoprotein (ox-LDL) and oxidative stress. Antioxidants 
can reduce or direct quench the free radicals produced by 
the body, inhibit lipid peroxidation, protect the function 
of vascular endothelial cells, reduce monocyte adhesion 
and foam cell formation, and prohibit the proliferation of 
smooth muscle cells.10,11  
Studies have shown that by promoting the formation of 
foam cells, ox-LDL can induce adhesion of monocytes to 
endothelial cells and chemotaxis of monocytes to 
subendothelium, promote degradation and proliferation 
of macrophages, enhance proliferation of endothelial 
cells and smooth muscle cells, increase adhesion, 
aggregation and thrombosis of platelet, facilitate 
vasoconstriction, induce injury of endothelial cells, 
activate nuclear factor-țB (NF-țB), intensify the 
inflammatory response of AS, and therefore, promote the 
initiation and development of AS.12-15 As a promoter of 
CD36 receptor,16 PPARȖ can increase the uptake of 
ox-LDL by macrophage, forming positive feedback, and 
eventually promote the formation of AS.  
It has been proven that NF-țB dimer is inactive in 
quiescent cells by binding to its inhibitory protein IțBs. 
When it is activated, NF-țB dimer can adjust over 160 
genes and their expression products including 
inflammatory factors and cytokines are involved in the 
process of atherosclerosis formation.17,18 Inappropriate 
activation of NF-țB is the critical step to induce 
inflammation and oxidative damage, therefore, to control 
the inappropriate activation of NF-țB is an important 
strategy for treatment of AS.19 SOD plays an important 
role in the balance of oxidation and antioxidant of the 
body, besides, it can clear the super-anion radicals and 
protect cells from damage. Thus its activity level reflects 
the body's ability to eliminate oxygen free radicals. MDA 
is a stable end product of metabolism after the lipid 
peroxidation of cell membrane, which can promote 
cross-linking polymerization of the protein to cause cell 
injury. In the pathogenesis of AS, the activity of SOD 
decreases, and the ability to eliminate oxygen free 
radicals in the body also declines, while MDA regarded 
as the lipid peroxided end product increases.  
SX is mainly composed of Chuan Xiong (Rhizoma 
Chuanxiong) and Bing Pian (Borneolum). Chuan Xiong 
(Rhizoma Chuanxiong) can expand the coronary artery, 
increase coronary blood flow, reduce the consumption of 
oxygen in myocardium, and act as the “calcium 
antagonist”.20 Bing Pian (Borneolum) can extend the 
time of the body resistance to oxygen, being distributed 
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rapidly to the heart, lungs, brain and other organs and 
tissues rich in blood flow.21  
In the authors’ experiment, it was found that the level of 
ox-LDL and the expression of PPARȖ protein in AS rats 
were significantly higher than those in the normal control 
group (P<0.01), suggesting that ox-LDL and PPARȖ play 
an important role in the occurrence and development of 
atherosclerosis. These indexes were significantly 
decreased in the SX middle and high dose groups, 
indicating that a large number of ox-LDL are generated 
during the process of AS with activation of the 
expression of PPARȖ protein; SX can inhibit the 
production of ox-LDL and decrease the expression of 
PPARȖ. It was found that in the SX middle and high dose 
groups MDA content reduced significantly, meaning that 
it can repair and protect the integrity of cell membranes. 
The expression of NF-țB in the aortic arch increased in 
the model group, while the expression of NF-țB reduced 
in the SX middle and high dose groups. Intracellular 
SOD activity in the model group decreased in 
comparison with that in the normal control group, while 
the SOD activity in the SX middle and high dose groups 
were significantly increased as compared to that in the 
model group, showing that SX can protect SOD activity 
in cells, thus enhancing antioxidant capacity of aortic 
cells .22  
In summary, SX can inhibit oxidative stress and decrease 
inflammation, so as to play an important role in resisting 
the occurrence and development of atherosclerosis. 
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